Literature DB >> 19273211

TGF-beta signal transduction in chronic kidney disease.

H William Schnaper1, Sara Jandeska, Constance E Runyan, Susan C Hubchak, Rajit K Basu, Jessica F Curley, Ronald D Smith, Tomoko Hayashida.   

Abstract

Transforming growth factor (TGF)-beta is a central stimulus of the events leading to chronic progressive kidney disease, having been implicated in the regulation of cell proliferation, hypertrophy, apoptosis and fibrogenesis. The fact that it mediates these varied events suggests that multiple mechanisms play a role in determining the outcome of TGF-beta signaling. Regulation begins with the availability and activation of TGF-beta and continues through receptor expression and localization, control of the TGF-beta family-specific Smad signaling proteins, and interaction of the Smads with multiple signaling pathways extending into the nucleus. Studies of these mechanisms in kidney cells and in whole-animal experimental models, reviewed here, are beginning to provide insight into the role of TGF-beta in the pathogenesis of renal dysfunction and its potential treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273211      PMCID: PMC4367189          DOI: 10.2741/3389

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  200 in total

1.  Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling.

Authors:  Jurgen J W Mulsow; R William G Watson; John M Fitzpatrick; P Ronan O'Connell
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

Review 2.  Modulation of Wnt signaling by Axin and Axil.

Authors:  A Kikuchi
Journal:  Cytokine Growth Factor Rev       Date:  1999 Sep-Dec       Impact factor: 7.638

3.  Protein kinase CK2 mediates TGF-beta1-stimulated type IV collagen gene transcription and its reversal by estradiol.

Authors:  M Zdunek; S Silbiger; J Lei; J Neugarten
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

4.  Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.

Authors:  S J Shankland; F Eitner; K L Hudkins; T Goodpaster; V D'Agati; C E Alpers
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

5.  Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription.

Authors:  W Zhang; J Ou; Y Inagaki; P Greenwel; F Ramirez
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

6.  Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.

Authors:  C E Pierreux; F J Nicolás; C S Hill
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

7.  Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.

Authors:  Franck Lebrin; Marie-José Goumans; Leon Jonker; Rita L C Carvalho; Gudrun Valdimarsdottir; Midory Thorikay; Christine Mummery; Helen M Arthur; Peter ten Dijke
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

8.  Pleiotropic and diverse expression of ZFHX1B gene transcripts during mouse and human development supports the various clinical manifestations of the "Mowat-Wilson" syndrome.

Authors:  Guillaume Bassez; Olivier J A Camand; Valère Cacheux; Alexandra Kobetz; Florence Dastot-Le Moal; Dominique Marchant; Martin Catala; Marc Abitbol; Michel Goossens
Journal:  Neurobiol Dis       Date:  2004-03       Impact factor: 5.996

9.  MAP-kinase activity necessary for TGFbeta1-stimulated mesangial cell type I collagen expression requires adhesion-dependent phosphorylation of FAK tyrosine 397.

Authors:  Tomoko Hayashida; Ming-Hua Wu; Amy Pierce; Anne-Christine Poncelet; John Varga; H William Schnaper
Journal:  J Cell Sci       Date:  2007-12-01       Impact factor: 5.285

Review 10.  TGF-beta signaling: a tale of two responses.

Authors:  Rod A Rahimi; Edward B Leof
Journal:  J Cell Biochem       Date:  2007-10-15       Impact factor: 4.429

View more
  60 in total

1.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

Review 2.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

3.  Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria.

Authors:  Dan Wang; Chunsun Dai; Yingjian Li; Youhua Liu
Journal:  Kidney Int       Date:  2011-08-10       Impact factor: 10.612

4.  Cross regulation between hypoxia-inducible transcription factor-1α (HIF-1α) and transforming growth factor (TGF)-ß1 mediates nickel oxide nanoparticles (NiONPs)-induced pulmonary fibrosis.

Authors:  Fenghua Qian; Mindi He; Weixia Duan; Lin Mao; Qian Li; Zhengping Yu; Zhou Zhou; Yong Zhang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

5.  Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signaling.

Authors:  Chunsun Dai; Xiaoyan Wen; Weichun He; Youhua Liu
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

6.  GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure.

Authors:  Marianne Pons; Leonidas G Koniaris; Sharon M Moe; Juan C Gutierrez; Aurora Esquela-Kerscher; Teresa A Zimmers
Journal:  Surgery       Date:  2018-05-03       Impact factor: 3.982

Review 7.  Heat shock proteins and kidney disease: perspectives of HSP therapy.

Authors:  Natalia Chebotareva; Irina Bobkova; Evgeniy Shilov
Journal:  Cell Stress Chaperones       Date:  2017-04-13       Impact factor: 3.667

8.  Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis.

Authors:  Sha Hao; Weichun He; Yingjian Li; Hong Ding; Yayi Hou; Jing Nie; Fan Fan Hou; Michael Kahn; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2011-08-04       Impact factor: 10.121

9.  Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis.

Authors:  Na Liu; Jian-Kan Guo; Maoyin Pang; Evelyn Tolbert; Murugavel Ponnusamy; Rujun Gong; George Bayliss; Lance D Dworkin; Haidong Yan; Shougang Zhuang
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

10.  P311 promotes renal fibrosis via TGFβ1/Smad signaling.

Authors:  Zhihui Yao; Sisi Yang; Weifeng He; Lian Li; Rui Xu; Xiaorong Zhang; Haisheng Li; Rixing Zhan; Wei Sun; Jianglin Tan; Junyi Zhou; Gaoxing Luo; Jun Wu
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.